ChristopherKentDykeMD

Cardiology • Denver, CO

Cardiothoracic Imaging, Non-Invasive Cardiology, Preventive Cardiology

Medical Director of Cardiac Imaging

Join to view full profile

Dr. Dyke is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Dyke's full profile

Already have an account?

Office
1400 Jackson Street #J227
Denver, CO 80206
Phone+1 303-398-1700

Fax+1 303-398-1476
Is this information wrong?

Education & Training

National Institutes of Health Clinical CenterFellowship, Advanced Cardiac Imaging, 2002 - 2004
Duke University HospitalFellowship, Cardiovascular Disease, 1998 - 2002
University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1995 - 1998
University of Texas Southwestern Medical SchoolClass of 1995

Certifications & Licensure

CO State Medical License 2019 - 2025
AK State Medical License 2006 - 2021
NC State Medical License 2003 - 2007
VA State Medical License 1999 - 2004
MD State Medical License 2002 - 2004
TX State Medical License 1996 - 2001
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011

Publications & Presentations

PubMed

1 citations
Society for cardiovascular magnetic resonance recommendations for training and competency of CMR technologists.
Stephen Darty, Elizabeth Jenista, Raymond J Kim, Christopher Dyke, Orlando P Simonetti, Monika Radike, Jen Bryant, Chris Benny Lawton, Nicole Freitag, Dipan J Shah, Ch...> ;Journal of Cardiovascular Magnetic Resonance. 2022 Dec 5
8 citations
Implications of the 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Chest Pain Guideline for Cardiovascular Imaging: A Multisociety Viewpoint.
Ron Blankstein, Leslee J Shaw, Martha Gulati, Michael K Atalay, Jeroen Bax, Dennis A Calnon, Christopher K Dyke, Maros Ferencik, Jonathan F Heitner, Timothy D Henry, J...> ;JACC. Cardiovascular Imaging. 2022 May 1
6 citations
The Future of Cardiac Magnetic Resonance Clinical Trials.
Mark G Rabbat, Raymond Y Kwong, John F Heitner, Alistair A Young, Sujata M Shanbhag, Steffen E Petersen, Joseph B Selvanayagam, Colin Berry, Eike Nagel, Bobak Heydari,...> ;JACC. Cardiovascular Imaging. 2022 Dec 1
3 citations
Piloting the FIRE: A Novel Error Management Training Simulation Curriculum for Fasciotomy Instruction
Brenton R. Franklin, Christopher Dyke, Steven J. Durning, Anthony R. Artino, Mark W. Bowyer, Walter B. Kucera, E. Matthew Ritter> ;Journal of Surgical Education. 2021 Mar 1
5 citations
Early implementation of Fundamentals of Endoscopic Surgery training using a simulation-based mastery learning curriculum.
Christopher Dyke, Brenton R. Franklin, W. Brian Sweeney, E. Matthew Ritter> ;Surgery. 2021 May 1
Fundamentals of Anorectal Technical Skills: A Concise Surgical Skills Course.
Walter B. Kucera, Christopher Dyke, E. Matthew Ritter, Anthony R. Artino, Steven J. Durning, W. Brian Sweeney> ;Military Medicine. 2020 Sep 18
56 citations
Society for Cardiovascular Magnetic Resonance (SCMR) guidance for the practice of cardiovascular magnetic resonance during the COVID-19 pandemic.
Yuchi Han, Tiffany Chen, Jennifer Bryant, Chiara Bucciarelli-Ducci, Christopher Dyke, Michael D. Elliott, Victor A. Ferrari, Matthias G. Friedrich, Chris Lawton, Warre...> ;Journal of Cardiovascular Magnetic Resonance. 2020 Apr 27
8 citations
Aminophylline shortage and current recommendations for reversal of vasodilator stress: An ASNC information statement endorsed by SCMR
Aiden Abidov, Vasken Dilsizian, Rami Doukky, W. Lane Duvall, Christopher Dyke, Michael D. Elliott, Fadi G. Hage, Milena J. Henzlova, Nils P. Johnson, Ronald G. Schwart...> ;Journal of Nuclear Cardiology. 2019 Jun 1
4 citations
Aminophylline shortage and current recommendations for reversal of vasodilator stress: an ASNC information statement endorsed by SCMR.
Aiden Abidov, Vasken Dilsizian, Rami Doukky, W. Lane Duvall, Christopher Dyke, Michael D. Elliott, Fadi G. Hage, Milena J. Henzlova, Nils P. Johnson, Ronald G. Schwart...> ;Journal of Cardiovascular Magnetic Resonance. 2018 Dec 20
36 citations
Association of Unrecognized Myocardial Infarction With Long-term Outcomes in Community-Dwelling Older Adults: The ICELAND MI Study.
Tushar Acharya, Thor Aspelund, Torfi F. Jonasson, Erik B. Schelbert, Jane J. Cao, Bharath Sathya, Christopher K. Dyke, Anthony H. Aletras, Sigurdur Sigurdsson, Gudmund...> ;JAMA Cardiology. 2018 Nov 1
36 citations
Sudden Death in Patients With Coronary Heart Disease Without Severe Systolic Dysfunction.
, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,...> ;JAMA Cardiology. 2018 Jul 1
215 citations
Prevalence and prognosis of unrecognized myocardial infarction determined by cardiac magnetic resonance in older adults.
Erik B. Schelbert, Jie J Cao, Sigurdur Sigurdsson, Thor Aspelund, Peter Kellman, Anthony H. Aletras, Christopher K. Dyke, Gudmundur Thorgeirsson, Gudny Eiriksdottir, L...> ;JAMA. 2012 Sep 5
110 citations
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease
Mark Y. Chan, Mauricio G. Cohen, Christopher K. Dyke, Shelley K. Myles, Laura G. Aberle, Min Lin, James S Walder, Steven R. Steinhubl, Ian C. Gilchrist, Neal S. Kleima...> ;Circulation. 2008 Jun 3
11 citations
Age-Related Vascular Stiffness and Left Ventricular Size After Myocardial Infarction
Glenn A. Hirsch, W. Patricia Ingkanisorn, Steven P. Schulman, Gary Gerstenblith, Christopher K. Dyke, Kenneth L. Rhoads, Richard E. Thompson, Anthony H. Aletras, Andre...> ;The American Journal of Geriatric Cardiology. 2007 Jul 1
159 citations
First-in-Human Experience of an Antidote-Controlled Anticoagulant Using RNA Aptamer Technology: A Phase 1a Pharmacodynamic Evaluation of a Drug-Antidote Pair for the C...
Christopher K. Dyke, Steven R. Steinhubl, Neal S. Kleiman, Richard O. Cannon, Laura G. Aberle, Min Lin, Shelley K. Myles, Chiara Melloni, Robert A. Harrington, John H....> ;Circulation. 2006 Dec 5
205 citations
Prognosis of Negative Adenosine Stress Magnetic Resonance in Patients Presenting to an Emergency Department With Chest Pain
W. Patricia Ingkanisorn, Raymond Y. Kwong, Nicole S. Bohme, Nancy L. Geller, Kenneth L. Rhoads, Christopher K. Dyke, D. Ian Paterson, Mushabbar A. Syed, Anthony H. Ale...> ;Journal of the American College of Cardiology. 2006 Apr 4
18 citations
Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery disease
Richard C. Becker, John H. Alexander, Christopher K. Dyke, Yao Huang, Henock Saint-Jacques, Vic Hasselblad, Robert A. Harrington, Edwin G. Bovill> ;Thrombosis Research. 2006 Jan 1
35 citations
First experience with direct, selective factor Xa inhibition in patients with non-ST-elevation acute coronary syndromes: results of the XaNADU-ACS Trial
John H. Alexander, H. Yang, Richard C. Becker, K. Kodama, Shaun G. Goodman, Christopher K. Dyke, Neal S. Kleiman, Judith S. Hochman, Peter B. Berger, Eric A. Cohen, A....> ;Journal of Thrombosis and Haemostasis. 2005 Mar 1
2 citations
Combined coagulation phase-directed factor Xa inhibition with heparin compounds and DX-9065a - A direct and selective antagonist
Richard C. Becker, John H. Alexander, YouFu Li, Edwin G. Bovill, Frederick A. Spencer, Thomas L. Robertson, Satoshi Kunitada, Christopher K. Dyke, Robert A. Harrington> ;Thrombosis and Haemostasis. 2004 Dec 1
12 citations
Development of DX-9065a, a novel direct factor Xa antagonist, in cardiovascular disease
Richard C. Becker, John H. Alexander, Christopher K. Dyke, Robert A. Harrington> ;Thrombosis and Haemostasis. 2004 Nov 8
38 citations
Initial experience with factor-Xa inhibition in percutaneous coronary intervention: The XaNADU-PCI pilot
John H. Alexander, Christopher K. Dyke, H. Yang, Richard C. Becker, Vic Hasselblad, Linda A. Zillman, Neal S. Kleiman, Judith S. Hochman, P. B. Berger, E. A. Cohen, A....> ;Journal of Thrombosis and Haemostasis. 2004 Feb 1
16 citations
Artifact suppression in imaging of myocardial infarction using B1-weighted phased-array combined phase-sensitive inversion recovery†
Peter Kellman, Christopher K. Dyke, Anthony H. Aletras, Elliot R. McVeigh, Andrew E. Arai> ;Magnetic Resonance in Medicine. 2004 Feb 1
32 citations
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute co...
Debabrata Mukherjee, Kenneth W. Mahaffey, David J. Moliterno, Robert A. Harrington, Jay S. Yadav, Karen S. Pieper, Dianne Gallup, Christopher K. Dyke, Matthew T. Roe, ...> ;American Heart Journal. 2002 Dec 1
62 citations
First Experience With Direct Factor Xa Inhibition in Patients With Stable Coronary Disease A Pharmacokinetic and Pharmacodynamic Evaluation
Christopher K. Dyke, Richard C. Becker, Neal S. Kleiman, Judith S. Hochman, Edwin G. Bovill, A. Michael Lincoff, Gary Gerstenblith, Vladimir Dzavik, Laura H. Gardner, ...> ;Circulation. 2002 May 21
58 citations
Misreporting of myocardial infarction end points: Results of adjudication by a central clinical events committee in the PARAGON-B trial ☆ ☆☆ ★
Kenneth W. Mahaffey, Matthew T. Roe, Christopher K. Dyke, L. Kristin Newby, Neal S. Kleiman, Patty Connolly, Lisa G. Berdan, Rodney Sparapani, Kerry L. Lee, Paul W. Ar...> ;American Heart Journal. 2002 Feb 1
Join now to see all

Press Mentions

Cardiologist Dr. Christopher Dyke Joins National Jewish HealthJanuary 6th, 2021
Aminophylline Shortage and Current Recommendations for Reversal of Vasodilator Stress: An ASNC Information Statement Endorsed by SCMRDecember 20th, 2018